Seoul, South Korea

Seo Hyun Yoon

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seo Hyun Yoon. Retrieved from https://idiyas.com/inventor/seo-hyun-yoon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seo Hyun Yoon: Innovator in Antihypertensive Pharmaceutical Composition

Introduction

Seo Hyun Yoon is a notable inventor based in South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive medications. Her work focuses on innovative compositions that aim to improve patient outcomes in hypertension management.

Latest Patents

Seo Hyun Yoon holds a patent for an antihypertensive pharmaceutical composition. This invention includes Fimasartan, an angiotensin II receptor blocker, and Amlodipine, a calcium channel blocker. The combination of these compounds is designed to effectively manage high blood pressure.

Career Highlights

Seo Hyun Yoon is associated with Boryung Pharmaceutical Co., Ltd., where she has been instrumental in advancing research and development in antihypertensive therapies. Her expertise in pharmaceutical formulations has contributed to the company's reputation in the industry.

Collaborations

Seo Hyun Yoon collaborates with esteemed colleagues, including Seung Ho Kim and Ji Han Kim. Their teamwork fosters a productive environment for innovation and development in pharmaceutical sciences.

Conclusion

Seo Hyun Yoon's contributions to antihypertensive pharmaceutical compositions highlight her role as an innovator in the field. Her work continues to impact the management of hypertension, showcasing the importance of collaboration and research in pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…